Purpose: To evaluate the clinical data and treatment outcomes of 3 different methods for redo hypospadias surgery. Patients and Methods: We retrospectively reviewed the data of 39 patients with redo hypospadias surgery between January 2010 and April 2019 at our clinic. A ventral preputial onlay flap, a preputial tubular flap, and a full thickness skin tubular graft were used in redo hypospadias surgery. We evaluated these methods regarding age, number, and type of previous repairs, catheter time, chordee, length of the urethral defect, operation time, complications, and follow-up results. T tests and Fisher’s exact tests were used to compare differences between groups. Results: The mean operation age of the patients was 5.23 years. Sixteen patients had a single, 21 had 2, and 2 patients had 3 previous repairs. The position of the urethral meatus was perineal in 2, penoscrotal in 6, mid penile in 21, and distal penile in 10 patients. The initial repairs comprised 19 tubularized incised plates (TIP), 12 Mathieu procedures, 5 tubularized preputial flaps, 2 full thickness skin tubular grafts, and 1 onlay island flap repair. Eight full thickness skin tubular grafts, 18 onlay preputial island flaps, and 13 preputial tubular flaps were used for redo surgery. The success rate was 79.1%. Eight wound infections, 6 glans dehiscences, 13 fistulas, 12 meatal stenoses, and 5 urethral diverticulas were seen in the patients. The rates of these complications, Cystofix requirement, and reoperation were higher in the skin tubular graft group but this was not statistically significant (p > 0.05). One patient with graft contracture required a redo skin graft urethroplasty. The mean follow-up duration was18 months. Conclusion: Preputial tissue should be preferred in the presence of redo hypospadias surgery. In the absence of preputial tissue other tissues such as oral or buccal mucosa should be preferred instead of skin grafts.

1.
Safwat
AS
,
Elderwy
A
,
Hammouda
HM
.
Which type of urethroplasty in failed hypospadias repair?
An 8-year follow up. J Pediatr Urol
2013
;9(6 PtB):1150-1154.
2.
Nitkunan
T
,
Johal
N
,
O’Malley
K
,
Cuckow
P
.
Secondary hypospadias repair in two stages
.
J Pediatr Urol
.
2006
Dec
;
2
(
6
):
559
63
.
[PubMed]
1477-5131
3.
Al-Sayyad
A
,
Pike
JG
,
Leonard
MP
.
Redo hypospadias repair: experience at a tertiary care children’s hospital
.
Can Urol Assoc J
.
2007
Mar
;
1
(
1
):
47
51
.
[PubMed]
1911-6470
4.
Pandey
A
,
Barta-Kelemen
AM
,
Borisenkov
M
,
Keller
H
.
The Staged Urethroplasty with Vascularised Scrotal Flap and Buccal Mucosa Graft after Failed Hypospadias Surgery: A Reliable Technique with a Novel Tool
.
Urol Int
.
2017
;
99
(
1
):
36
42
.
[PubMed]
0042-1138
5.
Andrich
DE
,
Mundy
AR
.
What is the best technique for urethroplasty?
Eur Urol
.
2008
Nov
;
54
(
5
):
1031
41
.
[PubMed]
0302-2838
6.
Metro
MJ
,
Wu
HY
,
Snyder
HM
 3rd
,
Zderic
SA
,
Canning
DA
.
Buccal mucosal grafts: lessons learned from an 8-year experience
.
J Urol
.
2001
Oct
;
166
(
4
):
1459
61
.
[PubMed]
0022-5347
7.
Snodgrass
W
,
Bush
NC
.
Re-operative urethroplasty after failed hypospadias repair: how prior surgery impacts risk for additional complications
.
J Pediatr Urol
.
2017
Jun
;
13
(
3
):
289.e1
6
.
[PubMed]
1477-5131
8.
Jayanthi
VR
,
McLorie
GA
,
Khoury
AE
,
Churchill
BM
.
Can previously relocated penile skin be successfully used for salvage hypospadias repair?
J Urol
.
1994
Aug
;
152
(
2 Pt 2
):
740
3
.
[PubMed]
0022-5347
9.
Emir
L
,
Erol
D
.
Mathieu urethroplasty as a salvage procedure: 20-year experience
.
J Urol
.
2003
Jun
;
169
(
6
):
2325
6
.
[PubMed]
0022-5347
10.
Yang
SS
,
Chen
SC
,
Hsieh
CH
,
Chen
YT
.
Reoperative Snodgrass procedure
.
J Urol
.
2001
Dec
;
166
(
6
):
2342
5
.
[PubMed]
0022-5347
11.
Emir
L
,
Germiyanoglu
C
,
Erol
D
.
Onlay island flap urethroplasty: a comparative analysis of primary versus reoperative cases
.
Urology
.
2003
Jan
;
61
(
1
):
216
9
.
[PubMed]
0090-4295
12.
Badawy
H
,
Soliman
A
,
Moussa
A
,
Youssef
M
,
Fahmy
A
,
Dawood
W
, et al.
Staged repair of redo and crippled hypospadias: analysis of outcomes and complications
.
J Pediatr Urol
.
2019
Apr
;
15
(
2
):
151.e1
10
.
[PubMed]
1477-5131
13.
Gill
NA
,
Hameed
A
.
Management of hypospadias cripples with two-staged Bracka’s technique
.
J Plast Reconstr Aesthet Surg
.
2011
Jan
;
64
(
1
):
91
6
.
[PubMed]
1748-6815
14.
Mundy
AR
.
Failed hypospadias repair presenting in adults
.
Eur Urol
.
2006
May
;
49
(
5
):
774
6
.
[PubMed]
0302-2838
15.
Hardwicke
J
,
Jones
E
,
Wilson-Jones
N
.
Optimization of silicone urinary catheters for hypospadias repair
.
J Pediatr Urol
.
2010
Aug
;
6
(
4
):
385
8
.
[PubMed]
1477-5131
16.
Xie
QG
,
Su
C
,
Li
ZQ
,
Li
SS
,
Xu
Z
,
Sun
JJ
, et al.
[Foley catheter versus urethral stent plus gastric tube for urine drainage following urethroplasty]
.
Zhonghua Nan Ke Xue
.
2014
May
;
20
(
5
):
439
41
.
[PubMed]
1009-3591
17.
Lansdale
N
,
Henderson
L
,
Hennayake
S
.
Novel use of an osmotic self-inflating tissue expander for hypospadias revision surgery
.
Urology
.
2015
Apr
;
85
(
4
):
924
6
.
[PubMed]
0090-4295
18.
Mir
T
,
Simpson
RL
,
Hanna
MK
.
The use of tissue expanders for resurfacing of the penis for hypospadias cripples
.
Urology
.
2011
Dec
;
78
(
6
):
1424
9
.
[PubMed]
0090-4295
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.